CTVA

AI Research

Corteva Plans Seed Business Spin-Off Investor Day Sept 2026 → 2026 EBITDA Guided $4.0-4.2B

Corteva will host dual Investor Days on September 15, 2026 at NYSE to introduce its seed/genetics business as a prospective standalone public company. The company projects 2026 operating EBITDA of $4.0–$4.2B and operating EPS of $3.45–$3.70, with Deutsche Bank maintaining a $90 Buy target. Stock trades at $80.35 with Wolfe Research at $86 Outperform, though separation execution risk remains a key concern.